An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia

Benzer Materyaller

• An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
  Yazar:: Pandina Gahan, ve diğerleri
  Baskı/Yayın Bilgisi: (2012-06-01)
• An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder
  Yazar:: Kent, Justine M., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study()
  Yazar:: Pandina, Gahan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
  Yazar:: Iwata, Nakao, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
  Yazar:: Ganguli, Rohan, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)